FindTrial
Sign In

Study on the efficacy and safety of AP regimen in the chronotherapy of advanced non-small cell lung Cancer

Study on the efficacy and safety of AP regimen in the chronotherapy of advanced non-small cell lung Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600119631
Enrollment
Unknown
Registered
2026-03-02
Start date
2026-03-05
Completion date
Unknown
Last updated
2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced non-small cell lung cancer

Interventions

Morning group:None
Afternoon group:N

Sponsors

Guangdong Second Provincial General Hospital (Guangdong Provincial Emergency Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged 18 or above; 2. Pathological diagnosis: Stage III-IV NSCLC (8th Edition AJCC); 3. The PS score sheet is 0 points and 1 point. 4. Previously received AP chemotherapy regimens;

Exclusion criteria

Exclusion criteria: 1. Combined with a second primary tumor; 2. Have received other anti-tumor treatments; 3. No imaging reexamination was conducted; 4. The clinical TNM stage is I-II NSCLC.

Design outcomes

Primary

MeasureTime frame
The diameter of the tumor.;—

Secondary

MeasureTime frame
Safety;—

Countries

China

Contacts

Public ContactXuhui Zhang

Guangdong Second Provincial General Hospital (Guangdong Provincial Emergency Hospital)

9158863@qq.com+86 20 89169168

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026